MicroRNAs miR-4535 and miR-1915-5p in amniotic fluid as predictive biomarkers for chorioamnionitis

Chihiro Kiyoshima1, Naoto Shirasu2,3, Daichi Urushiyama1

  • 1Department of Obstetrics & Gynecology, Fukuoka University, Fukuoka, Japan.

Future Science OA
|May 28, 2021
PubMed
Abstract

Insights

Two microRNAs, miR-4535 and miR-1915-5p, show high diagnostic accuracy for severe chorioamnionitis. These biomarkers are linked to maternal and fetal inflammation, aiding in diagnosis.

Area of Science:

  • Reproductive Medicine
  • Molecular Diagnostics
  • MicroRNA Research

Background:

  • Severe chorioamnionitis poses significant risks to maternal and fetal well-being.
  • Accurate and early diagnosis is crucial for effective management.

Purpose of the Study:

  • To investigate the clinical significance of specific microRNAs (miRNAs) in severe chorioamnionitis.
  • To evaluate miR-4535 and miR-1915-5p as potential diagnostic biomarkers.

Main Methods:

  • Amniotic fluid samples were collected from 37 patients diagnosed with severe chorioamnionitis.
  • MicroRNA expression was analyzed using miRNA array and digital droplet PCR (ddPCR).
  • Diagnostic accuracy was assessed via receiver operating characteristic (ROC) curve analysis.

Main Results:

  • Expression levels of miR-4535 and miR-1915-5p were significantly correlated with 16S rDNA copy numbers.
  • These miRNAs demonstrated exceptionally high diagnostic accuracy for severe chorioamnionitis.
  • Elevated miRNA expression was associated with maternal and fetal inflammatory markers.

Conclusions:

  • miR-4535 and miR-1915-5p are identified as promising biomarkers for diagnosing severe chorioamnionitis.
  • These miRNAs offer a potential tool for improved clinical management of this condition.